No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial
EuroIntervention · 2023
DOI: 10.4244/eij-d-23-00112 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EuroIntervention, 2023. Verfasst von Marc-André d'Entremont und 21 weiteren Autor:innen. Beteiligte Einrichtung: Sherbrooke University Hospital Center (CHUS), Sherbrooke, QC, Canada. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The optimal strategy to prevent no-reflow in ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI) is unknown. AIMS: We aimed to examine the effect of thrombectomy on the outcome of no-reflow in key subgroups and the adverse clinical outcomes associated with no-reflow. METHODS: We performed a post hoc analysis of the TOTAL Trial, a randomised trial of 10,732 patients comparing thrombectomy versus PCI alone. This analysis utilised the angiographic data of 1,800 randomly selected patients. RESULTS: No-reflow was diagnosed in 196 of 1,800 eligible patients (10.9%). No-reflow occurred in 95/891 (10.7%) patients randomised to thrombectomy compared with 101/909 (11.1%) in the PCI-alone arm (odds ratio [OR] 0.95, 95% confidence interval [CI]: 0.71-1.28; p-value=0.76). In the subgroup of patients who underwent direct stenting, those randomised to thrombectomy compared with PCI alone experienced less no-reflow (19/371 [5.1%] vs 21/216 [9.7%], OR 0.50, 95% CI: 0.26-0.96). In patients who did not undergo direct stenting, there was no difference between the groups (64/504 [12.7%] vs 75/686 [10.9%)], OR 1.18, 95% CI: 0.82-1.69; interaction p-value=0.02). No-reflow patients had a significantly increased risk of experiencing the primary composite outcome (cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or NYHA Class IV heart failure) at 1 year (adjusted hazard ratio 1.70, 95% CI: 1.13-2.56; p-value=0.01). CONCLUSIONS: In patients with STEMI treated by PCI, thrombectomy did not reduce no-reflow in all patients but may be synergistic with direct stenting. No-reflow is associated with increased adverse clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Sherbrooke University Hospital Center (CHUS), Sherbrooke, QC, Canada.
- Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
- Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
- Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.
- Birmingham City Hospital, University of Birmingham, Birmingham, UK.
- Southlake Regional Health Centre, University of Toronto, Toronto, ON, Canada.
Zitieren
APA
d'Entremont, M. A., Alazzoni, A., Dzavik, V., Sharma, V., Overgaard, C. B., Lemaire-Paquette, S., Lamelas, P., Cairns, J. A., Mehta, S. R., Natarajan, M. K., Sheth, T. N., Schwalm, J. D., Rao, S. V., Stankovic, G., Kedev, S., Moreno, R., Cantor, W. J., Lavi, S., Bertrand, O. F., …, & Jolly, S. S. (2023). No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention. https://doi.org/10.4244/eij-d-23-00112
Vancouver
d'Entremont MA, Alazzoni A, Dzavik V, Sharma V, Overgaard CB, Lemaire-Paquette S, et al. No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial. EuroIntervention. 2023. doi:10.4244/eij-d-23-00112
BibTeX
@article{dEntremont2023,
author = {d'Entremont, Marc-André and Alazzoni, Ashraf and Dzavik, Vladimir and Sharma, Vinoda and Overgaard, Christopher B and Lemaire-Paquette, Samuel and Lamelas, Pablo and Cairns, John A and Mehta, Shamir R and Natarajan, Madhu K and Sheth, Tej N and Schwalm, John-David and Rao, Sunil V and Stankovic, Goran and Kedev, Sasko and Moreno, Raul and Cantor, Warren J and Lavi, Shahar and Bertrand, Olivier F and Nguyen, Michel and Couture, Étienne L and Jolly, Sanjit S},
title = {No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial},
journal = {EuroIntervention},
year = {2023},
doi = {10.4244/eij-d-23-00112}
}
EUVIMED